Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

Abstract Purpose of Review This review will aim to summarize the current body of
epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of …

Second generation antipsychotics (SGAs) have been implicated in the de novo emergence
and exacerbation of obsessive-compulsive symptoms (OCS) in patients with schizophrenia …

BackgroundObsessive-compulsive disorder (OCD) is common in clozapine-treated patients
although the actual prevalence, phenomenology and risk factors remain unclear. The aim of …

Objective Antipsychotics have conflicting data with respect to obsessive–compulsive
disorder/symptoms (OCD/OCS), with some reporting causality and some reporting treatment …

Background: It is not uncommon to find obsessive-compulsive symptoms (OCS) in patients
treated with clozapine. These symptoms are attributed to anti-serotonergic effects of …

Insight into the biological pathomechanism of a clinical syndrome facilitates the
development of effective interventions. This paper applies this perspective to the important …

The prevalence of OCS and OCD is higher in schizophrenic patients than in the general
population. These disorders are sometimes induced by AAPs. There is higher frequency of …

The diagnostic criteria for obsessive-compulsive disorder (OCD) have undergone minor
changes in DSM-5 yet a major turnaround intervened in the overarching categorical …

One underrecognized adverse event of clozapine is the emergence or worsening of
obsessive‐compulsive symptoms (OCS). OCS, particularly violent thoughts, can be …